VX-809 10mg 10mg | Purity Not Available
Adooq Bioscience
VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF).
More Information Supplier PageSearch Results
VX-770 50mg 50mg | Purity Not Available
Adooq Bioscience
VX-770 5mg 5mg | Purity Not Available
Adooq Bioscience
VX-770 100mg 100mg | Purity Not Available
Adooq Bioscience
VX-770 10mg 10mg | Purity Not Available
Adooq Bioscience
VX-765 50mg 50mg | Purity Not Available
Adooq Bioscience
VX-765 is a novel Caspase-1 inhibitor,which is an enzyme that controls the generation of two cytokines, IL-1b and IL-18.
More Information Supplier PageVX-765 5mg 5mg | Purity Not Available
Adooq Bioscience
VX-765 is a novel Caspase-1 inhibitor,which is an enzyme that controls the generation of two cytokines, IL-1b and IL-18.
More Information Supplier PageVorinostat 500mg 500mg | Purity Not Available
Adooq Bioscience
Vorinostat is an inhibitor of HDACs, inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors.
More Information Supplier PageVorinostat 200mg 200mg | Purity Not Available
Adooq Bioscience
Vorinostat is an inhibitor of HDACs, inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors.
More Information Supplier PageVorinostat (SAHA) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Vorinostat is an inhibitor of HDACs, inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors.
More Information Supplier Page